In LCLs derived from a PVRL patient with a SEL1L3-reactive lymphoma BCR, constitutionally expressed SEL1L3 shows a higher molecular mass than mutated SEL1L3 and SEL1L3 expressed in LCLs derived from a healthy control. This evidence concerns the gene SEL1L3 and lymphoma.